Coagulation factor VIIa enhances programmed death-ligand 1 expression and its stability in breast cancer cells to promote breast cancer immune evasion
Journal of Thrombosis and Haemostasis · 2023
DOI: 10.1016/j.jtha.2023.08.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2023. Verfasst von Subhojit Paul und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Sciences, Indian Association for the Cultivation of Science, Kolkata, India. Hauptthemen laut MEDLINE: B7-H1 Antigen, Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Indian Association for the Cultivation of Science, Council of Scientific and Industrial Research, India.
Abstract (Originalsprache)
BACKGROUND: Immunotherapy for breast cancer has not gained significant success. Coagulation factor VIIa (FVIIa)-tissue factor (TF) mediated activation of protease-activated receptor 2 (PAR2) is shown to promote metastasis and secretion of the immune-modulatory cytokines but the role of FVIIa in cancer immunology is still not well understood. OBJECTIVES: Here, we aim to investigate whether FVIIa protects breast cancer cells from CD8 T-cell-mediated killing. METHODS: Peripheral blood mononuclear cell-derived CD8 T cells were cocultured with vehicle or FVIIa pretreated MDAMB468 cells. The proliferation and activity of CD8 T cells were measured by flow cytometry and ELISA. An allograft model, using wild-type or TF/PAR2-deleted 4T1 cells, was employed to determine the effect of FVIIa on breast cancer immune evasion in vivo. RESULTS: Here, we demonstrate that TF-FVIIa induces programmed death-ligand 1 (PD-L1) in breast cancer cells by activating PAR2. PAR2 activation triggers large tumor suppressor kinase 1 (LATS1) inactivation leading to loss of yes-associated protein (YAP)/transcriptional coactivator with PDZ-binding motif (TAZ) phosphorylation and subsequent nuclear localization of YAP/TAZ. YAP/TAZ inhibition reduces PD-L1 expression and increases CD8 T-cell activity. We further demonstrate that, apart from transcriptional induction of PD-L1, PAR2 activation also increases PD-L1 stability by enhancing its glycosylation through N-glycosyltransferases STT3A and STT3B. CONCLUSION: In a mouse model of breast cancer, tumor cell-specific PAR2 depletion leads to PD-L1 downregulation and increases anti-PD-1 immunotherapy efficacy. In conclusion, we showed that FVIIa-mediated signaling cascade in cancer cells serves as a tumor intrinsic mechanism of immunosuppression to promote cancer immune evasion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biological Sciences, Indian Association for the Cultivation of Science, Kolkata, India.
- Department of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, Texas.
- Department of General Surgery, Institute of Postgraduate Medical Education and Research, Kolkata, West Bengal, India.
- School of Biological Sciences, Indian Association for the Cultivation of Science, Kolkata, India. Electronic address: bcps@iacs.res.in.
Förderung
- Indian Association for the Cultivation of Science
- Council of Scientific and Industrial Research, India
Zitieren
APA
Paul, S., Das, K., Ghosh, A., Chatterjee, A., Bhoumick, A., Basu, A., & Sen, P. (2023). Coagulation factor VIIa enhances programmed death-ligand 1 expression and its stability in breast cancer cells to promote breast cancer immune evasion. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2023.08.008
Vancouver
Paul S, Das K, Ghosh A, Chatterjee A, Bhoumick A, Basu A, et al. Coagulation factor VIIa enhances programmed death-ligand 1 expression and its stability in breast cancer cells to promote breast cancer immune evasion. Journal of Thrombosis and Haemostasis. 2023. doi:10.1016/j.jtha.2023.08.008
BibTeX
@article{Paul2023,
author = {Paul, Subhojit and Das, Kaushik and Ghosh, Arnab and Chatterjee, Akash and Bhoumick, Avinandan and Basu, Abhimanyu and Sen, Prosenjit},
title = {Coagulation factor VIIa enhances programmed death-ligand 1 expression and its stability in breast cancer cells to promote breast cancer immune evasion},
journal = {Journal of Thrombosis and Haemostasis},
year = {2023},
doi = {10.1016/j.jtha.2023.08.008}
}
EUVIMED